Moderna tests mRNA shots to stop lyme disease
NCT ID NCT05975099
First seen Mar 23, 2026
Summary
This study tested two new mRNA vaccine candidates designed to prevent Lyme disease. It involved 807 healthy adults to see if the vaccines were safe and if they triggered a good immune response against the bacteria that causes Lyme. The study compared different doses of the vaccines against a placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYME DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ActivMed Research LLC
Newington, New Hampshire, 03801, United States
-
Advanced Primary and Geriatric Care
Rockville, Maryland, 20850, United States
-
Benchmark Research
Fort Worth, Texas, 76135, United States
-
Centennial Medical Group
Columbia, Maryland, 21045, United States
-
Charlottesville Medical Research Center, LLC
Charlottesville, Virginia, 22911, United States
-
Chase Medical Research, LLC
Waterbury, Connecticut, 06708, United States
-
Clinical Research Atlanta, headlands LLC
Stockbridge, Georgia, 30281, United States
-
Clinical Research Consulting, LLC
Milford, Connecticut, 06460, United States
-
Clinical Research Institute, Inc.
Minneapolis, Minnesota, 55402, United States
-
DM Clinical Research
Tomball, Texas, 77375, United States
-
DM Clinical Research - Brookline
Brookline, Massachusetts, 02445, United States
-
Encore Research Group-Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216, United States
-
Hatboro Medical Associates/CCT Research
Hatboro, Pennsylvania, 19040, United States
-
Johnson County Clin-Trials, Inc. (JCCT)
Lenexa, Kansas, 66219, United States
-
Lynn Health Science Institute
Oklahoma City, Oklahoma, 73112, United States
-
Meridian Clinical Research - Omaha
Omaha, Nebraska, 68134, United States
-
Rochester Clinical Research, Inc.
Rochester, New York, 14609, United States
-
Stamford Therapeutics Consortium
Stamford, Connecticut, 06905, United States
-
University Clinical Research-DeLand, LLC d/b/a Accel Research Sites
Lake Mary, Florida, 32746, United States
-
Velocity Clinical Research Providence
Providence, Rhode Island, 02886, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cell tracking could sharpen lyme disease diagnosis
- Lyme disease and parenthood: a hidden struggle revealed
- Lyme disease in pregnancy: new study tracks baby brain development
- New blood test aims to spot lyme disease in kids faster and more accurately
- New mRNA vaccine could stop lyme disease in its tracks
- Could a single pill stop lyme disease before it starts?